MetLife Investment Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-688
| Closed | -$156K | – | 2851 |
|
|
2022
Q3 | $156K | Buy |
688
+210
| +44% | +$47.5K | ﹤0.01% | 2447 |
|
|
2022
Q2 | $90.3K | Sell |
478
-184
| -28% | -$34.8K | ﹤0.01% | 2743 |
|
|
2022
Q1 | $165K | Buy |
+662
| New | +$165K | ﹤0.01% | 2469 |
|
|
2021
Q1 | – | Sell |
-402
| Closed | -$148K | – | 2338 |
|
|
2020
Q4 | $148K | Hold |
402
| – | – | ﹤0.01% | 2131 |
|
|
2020
Q3 | $98.3K | Hold |
402
| – | – | ﹤0.01% | 2217 |
|
|
2020
Q2 | $116K | Buy |
+402
| New | +$116K | ﹤0.01% | 2186 |
|
|
2020
Q1 | – | Sell |
-421
| Closed | -$188K | – | 2308 |
|
|
2019
Q4 | $188K | Hold |
421
| – | – | ﹤0.01% | 2009 |
|
|
2019
Q3 | $129K | Hold |
421
| – | – | ﹤0.01% | 2190 |
|
|
2019
Q2 | $134K | Buy |
+421
| New | +$134K | ﹤0.01% | 2244 |
|